Arbutus to Report Third Quarter 2024 Financial Results and Provide Corporate Update
An archived webcast will be available on the Arbutus website after the event. Arbutus Biopharma Corporation (Nasdaq: ABUS) is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics with distinct mechanisms of action,
1d
Sumitomo Mitsui DS Asset Management Company Ltd grew its position in Cognex Co. (NASDAQ:CGNX – Free Report) by 5.9% in the ...
In this article, we are going to take a look at where Cognex Corporation (NASDAQ:CGNX) stands against the other trending AI ...
It’s trading around 11.27% above our intrinsic value, which means if you buy Cognex today, you’d be paying a relatively fair ...
On Friday, Cognex Corp (CGNX) stock saw a modest uptick, ending the day at $40.75 which represents a slight increase of $0.76 or 1.90% from the prior close of $39.99. The stock opened at $40.33 and ...
NATICK, Ma., Oct. 11, 2024 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX) will release earnings for the third quarter of 2024 on Wednesday, October 30, 2024, after market close. The Company will ...
Needham analyst James Ricchiuti has maintained their bullish stance on COHR stock, giving a Buy rating on October 3. James Ricchiuti has given ...
On Tuesday, Cognex Corp (CGNX) stock saw a decline, ending the day at $39.69 which represents a decrease of $-0.46 or -1.15% from the prior close of $40.15. The stock opened at $40.06 and touched a ...
An S corp is an organization that has chosen to pass its tax burden to its shareholders, rather than report income, losses, deductions and credits directly to the Internal Revenue Service (IRS).
Liberty Media Corp. Series C Liberty Formula One 1.19% $23.46B Liberty Media Corp. Series A Liberty Formula One 1.09% $23.46B Liberty Broadband Corp. Cl A 4.70% $11.06B Liberty Broadband Corp.
Stephens分析师Tommy Moll将Cognex (NASDAQ: CGNX)的股票评级上调至增持，并将目标价从之前的$45上调至$55。这次上调反映了分析师对公司物流市场增长的信心，预计这将推动公司在来年恢复两位数的收入增长。
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback